Evidence map›Paper›PMID 40918462›Full record

ArticleOncology research2025

UHMK1 Promotes Prostate Cancer Progression through a Positive Feedback Loop with MTHFD2.

Chi Zhang, Xi Huang, Cheng Hu, Bowen Tang, Jianjie Wu, Zhuolun Sun, Weian Zhu, Xiangfu Zhou, Hengjun Xiao, Hua Wang

Abstract read
In one paragraph

Article in Oncology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chi ZhangDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
Xi HuangDepartment of Ultrasound, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
Cheng HuDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
Bowen TangDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
Jianjie WuDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
Zhuolun SunDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
Weian ZhuDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
Xiangfu ZhouDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
Hengjun XiaoDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
Hua WangDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: U2AF homology motif kinase 1 (UHMK1) has been associated with RNA processing and protein phosphorylation, thereby influencing tumor progression. The study aimed to explore its regulatory mechanisms and biological functions in human prostate cancer (PCa). Methods: In this study, we systematically evaluated the expression and prognostic significance of UHMK1 in public databases, followed by validation through immunohistochemistry (IHC) in PCa specimens. Both gain-of-function and loss-of-function experiments were conducted to elucidate the role of UHMK1 Results: Our findings revealed that UHMK1 expression was significantly upregulated in PCa tissues and correlated with poor patient prognosis, as demonstrated by analysis of public datasets and confirmed by immunohistochemical staining. Functional studies showed that UHMK1 depletion suppressed tumor cell proliferation and metastasis, while its overexpression promoted these processes. Mechanistically, we identified that UHMK1 phosphorylates nuclear receptor coactivator 3 (NCOA3), which subsequently activates activating transcription factor 4 (ATF4) to upregulate methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) transcription. Interestingly, MTHFD2 was found to reciprocally enhance UHMK1 expression, establishing a positive feedback loop. Conclusions: In conclusion, our data suggest that the UHMK1-MTHFD2 axis forms a positive feedback loop that drives PCa progression. Targeting this loop represents a promising therapeutic strategy for restraining prostate cancer development and progression.

Indexed as

AminohydrolasesMethylenetetrahydrofolate Dehydrogenase (NADP)Multifunctional EnzymesProstatic NeoplasmsProtein Serine-Threonine KinasesActivating Transcription Factor 4AnimalsCell Line, TumorCell ProliferationDisease ProgressionFeedback, PhysiologicalGene Expression Regulation, NeoplasticHumansMaleMiceMice, NudeActivating Transcription Factor 4AminohydrolasesATF4 protein, humanMethylenetetrahydrofolate Dehydrogenase (NADP)MTHFD2 protein, humanMultifunctional EnzymesProtein Serine-Threonine KinasesCancer progressionmethylenetetrahydrofolate dehydrogenase 2 (MTHFD2)positive feedback loopprostate cancer (PCa)U2AF Homology Motif Kinase 1 (UHMK1)

Identifiers

PMID40918462
PMCPMC12408860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.